All the high-grade glioma investigated for IDH1 mutation were negative (n = 45 [19,22,23,24]) contrasting with the grade 1 glioma (n = 15) harboring IDH1 mutation in all cases based on Jiang 2020 [25]. This evidence concerns the gene IDH1 and central nervous system cancer.